Levodropropizine

Levodropropizine is primarily used in clinical settings as a cough suppressant. It is indicated for:

• Treatment of dry cough due to upper respiratory tract infections.
• Management of persistent cough associated with bronchitis.

Its non-opioid nature makes it suitable for patients who may be at risk for opioid-related side effects. Furthermore, ongoing clinical trials are investigating its potential interactions with other medications, enhancing its therapeutic applications.

Levodropropizine exhibits significant biological activity as an antitussive agent with a mechanism that involves peripheral action rather than central suppression of cough reflex. Its pharmacokinetic profile indicates rapid absorption and elimination, with a half-life of approximately 2.3 hours after oral administration. The drug achieves peak plasma concentrations within 0.25 to 2 hours post-dose, demonstrating effective bioavailability. Additionally, it has been noted for its potential to induce allergic reactions in some patients, including cases of anaphylaxis.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.